James Jardine - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock James Jardine's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
James Jardine

James Jardine

Verified

Co-Host, Down the Security Rabbithole Podcast

Jacksonville

Final Covers

Video Games , Cars , Comics, Crime , TV, History , Movies, Games

Doesn’t Cover

Finance, Sport

Journalist Type

Seniority Positions

Content

Total articles 115

  • 03.26.25 -- MHRA Issues New Regulation On Modular And Point Of Care Manufacture Of ATMPs

    By Peter H. Calcott, James Jardine| Cell & Gene Verified FOCUS ON REGULATORY & COMPLIANCEThe U.K.'s MHRA has issued a new regulation to allow for decentralized manufacturing of cell and gene therapies (advanced therapeutic medicinal products), describing modular and point of care manufacturing. It becomes effective July 23, 2025. Insights From The FDA's New FAQThe FDA's new FAQ offers crucial insights into best practices, from regulatory meetings to quality control and preclinical studies. Dive in for expert guidance.

    By Peter H. Calcott, James Jardine · Cell & Gene

    Mar. 26, 2025

  • 03.03.25 -- Talent Logistics Turns Biotech Winter To Hiring Spring

    By Louis Garguilo Verified, Fahimeh Mirakhori, James Jardine, Doug Dayhoff| Outsourced Pharma@ Explore how shifting demand for oligos and peptides is driving outsourcing relationships and innovation in CDMO partnerships. Join our next Outsourced Pharma Live as we cover best practices for outsourcing these specialized therapeutics, focusing on capacity, regulatory challenges, and technology transfer. Register today to learn about the unique challenges and opportunities in scaling production for these complex molecules.

    By Louis Garguilo Verified, Fahimeh Mirakhori, James Jardine, Doug Dayhoff · Outsourced Pharma

    Mar. 03, 2025

  • 03.26.25 -- MHRA Issues New Regulation On Modular And Point Of Care Manufacture Of ATMPs

    By Peter H. Calcott, James Jardine| Cell & Gene Verified FOCUS ON REGULATORY & COMPLIANCEThe U.K.'s MHRA has issued a new regulation to allow for decentralized manufacturing of cell and gene therapies (advanced therapeutic medicinal products), describing modular and point of care manufacturing. It becomes effective July 23, 2025. Insights From The FDA's New FAQThe FDA's new FAQ offers crucial insights into best practices, from regulatory meetings to quality control and preclinical studies. Dive in for expert guidance.

    By Peter H. Calcott, James Jardine · Cell & Gene

    Mar. 26, 2025

As seen in

Company Info

Down the Security Rabbithole Podcast